Company / Depreciation & Amortization
Cytokinetics Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$10.1M
FY2025
5-year range
$2.3M / $11.9M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#64 of 168
Health Care
What the data says
At $10M, Cytokinetics's depreciation & amortization ranks #105 of 168 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $741,000 in FY2016 to $12M in FY2023.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +40.8%.
Improved from $12M to $10M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +40.8%
- 10-Year CAGR
- -
Sector benchmark
#105 of 168 in Health CareTop 62% of 168This company $10.1M Sector average $212.9M
▼
-95.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.8%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 6.2% year-over-year.
- Ranks #64 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.1M | +6.2% |
| FY2024 | $9.5M | -19.9% |
| FY2023 | $11.9M | +104.5% |
| FY2022 | $5.8M | +155.4% |
| FY2021 | $2.3M | +24.3% |
| FY2020 | $1.8M | +41.6% |
| FY2019 | $1.3M | +4.4% |
| FY2018 | $1.2M | -35.5% |
| FY2017 | $1.9M | +159.1% |
| FY2016 | $741.0K | +25.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026